ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 19.29 trillion as of March 25, 2025. Its market cap has increased by 177.51% in one year.

Market Cap

19.29T

Enterprise Value

19.24T

Revenue

102.85B

Ranking

n/a

PE Ratio

317.89

Stock Price

362,000.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 19.29T, an increase of 15,983.30%. That is a compound annual growth rate of 63.84%.

Market Cap History

Date	Market Cap	% Change
Mar 25, 2025	19.29T	16.96%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	76.44T
Celltrion	39.94T
Yuhan	9,419.29B
SK Biopharmaceuticals	8,410.84B
HLB Co., Ltd.	7,251.57B
Sam Chun Dang Pharm.	4,304.96B
LigaChem Biosciences	3,631.83B
PharmaResearch	3,319.49B

Market Cap Rankings